Innogy and Duke Energy are the anchor investors for a fund where CLP Group, American Electric, Chubu Electric and Bridgestone are LPs.
Month: July 2018
Allcure gets series B treatment with $103m
Concord Medical’s radiotherapy-focused spinoff has raised new funding from investors including a China Electronics Corporation Data-owned fund.
Analysis: Booking reserves $500m for Didi Chuxing
Booking provided ride services company Didi Chuxing with additional funding as part of a strategic partnership
Comcast helps kick in cash for K Health
Comcast Ventures was among the investors that put up $12.5m of financing for the care advice app developer.
Blast pushes seed round to $12m
CreditEase was among the investors that added $7m to the $5m game-based saving platform Blast raised in March.
TVision Insights draws attention in series B round
The Itochu-backed attention measurement technology provider has raised $11.5m, taking its overall funding to more than $20m.
GV measures Abacus exit
Certify has bought real-time expense reporting and management platform developer Abacus for an undisclosed sum.
M17 formally moves away from IPO
The Yahoo Japan and MCN-backed digital media company priced its initial public offering last month before failing to float.
Constellation consummates $60m IPO
The SR One-backed cancer drug developer cut the number of shares in the offering but priced them at the mid-point of its range.
Even adds $40m to its budget
The Qualcomm-backed budgeting app developer has secured $40m to increase its funding to $52m altogether.
Seeq finds corporates in $23m series B
Chevron Technology Ventures and Siemens’ Next47 unit were among the investors as Seeq looks to fund sales, marketing, global growth and R&D.
Brat grows up with $30m
Anchorage Capital has led a $30m funding round for Chernin Group-backed online video content studio Brat, which has now raised more than $42m in total.
Secret Escapes reveals $68m in funding
Old Mutual has supplied $68m to GV-backed online travel marketplace Secret Escapes, taking its funding to more than $251m to date.
Allakos accomplishes $128m IPO
The Roche-backed antibody developer floated above its range and has seen its stock almost double in price.